Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

19.11
-0.2300-1.19%
Post-market: 19.330.2200+1.15%19:13 EDT
Volume:41.37K
Turnover:790.49K
Market Cap:110.86M
PE:- -
High:19.18
Open:19.18
Low:19.05
Close:19.34
52wk High:21.88
52wk Low:14.38
Shares:5.80M
Float Shares:5.80M
Volume Ratio:0.60
T/O Rate:0.71%
Dividend:0.71
Dividend Rate:3.74%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Daiwa Raises CSPC Pharma Target Price to HK$11.2 on In-Line Interim Results

Stock News
·
5 mins ago

BofA Securities Lifts CSPC Pharma Target Price to HK$8.6 While Maintaining Underperform Rating

Deep News
·
Yesterday

UBS Lifts CSPC Pharma Price Target to HK$11.80, Reiterates Buy Rating

Deep News
·
Yesterday

Goldman Sachs Adjusts CSPC Pharma Target Price Upward While Retaining Buy Stance

Deep News
·
Yesterday

CSPC Pharmaceutical Group Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.
·
Yesterday

China's Haohai Biological H1 Revenue Falls, Partly Hurt by End of Brighten Optix Distribution

Reuters
·
Aug 21

TOT Biopharm FY26 H1 Net Loss Swings to RMB 59 Million; Revenue Drops 49.7% to RMB 246 Million

Reuters
·
Aug 21

UOB Kay Hian Upgrades CSPC Pharmaceutical Group to Buy from Sell; Price Target is HK$11.50

MT Newswires Live
·
Aug 21

Goldman Sachs Raises CSPC Pharma Price Target to HK$12.56, Reaffirms Buy Rating

Stock News
·
Aug 21

Wuxi Biologics (Cayman) Stock Rallies 2.7% in Hong Kong

Dow Jones
·
Aug 21

CSPC Pharmaceutical Group Stock Falls 3.5% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 21

美银证券上调石药集团目标价至8.6港元,维持“跑输大市”评级

Stock News
·
Aug 21

Akeso Says China NMPA Clears Phase I Trial for B7-H3 ADC Ak157d1 in Solid Tumors

Reuters
·
Aug 21

Akeso's Ak157d1 (B7-H3 ADC) Cleared for Phase I Trial in Solid Tumors, Adding a Third Differentiated ADC to Its Pipeline

THOMSON REUTERS
·
Aug 21

Morgan Stanley Raises CSPC Pharma Target Price to HK$12, Maintains Overweight Rating

Stock News
·
Aug 21

Moderna's Personalized mRNA Vaccine Achieves First Success, Chinese Innovators Line Up

Deep News
·
Aug 21

China's Simcere Pharmaceutical H1 Revenue Rises on Neuroscience, Autoimmune Drugs Strength

Reuters
·
Aug 20

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

Southbound Capital Daily: Net Selloff Hits HK$10.41B, Alibaba Draws Mainland Buying Pre-Earnings, Healthcare Stocks Split

Stock News
·
Aug 20

Hong Kong Stocks Rise on Thursday on Easing Bond Concerns, Tech Gains; CSPC Pharma Jumps 9%

MT Newswires Live
·
Aug 20